Get the Stockscreener App
136.34
7.07%
-10.33
Overview
News
Price History
Option Chain
Financials
Why ORCL Down?
Discussions
Forecast
Stock Split
Dividend History
Oracle Corp stock is traded at $136.34, with a volume of 32.30M.
It is down -7.07% in the last 24 hours and down -29.23% over the past month.
Oracle provides enterprise applications and infrastructure offerings through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used by the world's largest companies for high-volume online transaction processing workloads. Besides databases, Oracle also sells enterprise resource planning platforms and cloud infrastructure that play an increasingly important role in large language model training and inferencing.
See More
Previous Close:
$146.67
Open:
$145.6
24h Volume:
32.30M
Relative Volume:
1.21
Market Cap:
$391.75B
Revenue:
$61.02B
Net Income/Loss:
$15.61B
P/E Ratio:
25.62
EPS:
5.3211
Net Cash Flow:
$-13.18B
1W Performance:
-19.35%
1M Performance:
-29.23%
6M Performance:
-46.69%
1Y Performance:
-20.60%
1-Day Range:
$136.11
$146.55
1-Week Range:
$136.11
$171.20
52-Week Range:
$118.86
$345.72
Oracle Corp Stock (ORCL) Company Profile
Name
Oracle Corp
Sector
Industry
Phone
(737) 867-1000
Address
2300 ORACLE WAY, AUSTIN, CA
Compare ORCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
136.31 | 421.54B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
MSFT
Microsoft Corporation
|
393.46 | 3.08T | 305.45B | 119.26B | 77.41B | 15.98 |
|
PLTR
Palantir Technologies Inc
|
128.82 | 332.58B | 4.48B | 1.63B | 2.10B | 0.6363 |
|
CRWD
Crowdstrike Holdings Inc
|
379.40 | 104.71B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
409.89 | 80.16B | 7.05B | 1.34B | 1.35B | 8.0234 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Resumed | Goldman | Buy |
| Dec-11-25 | Reiterated | BMO Capital Markets | Outperform |
| Dec-03-25 | Initiated | Wells Fargo | Overweight |
| Nov-10-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-13-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-09-25 | Initiated | Robert W. Baird | Outperform |
| Sep-25-25 | Initiated | Rothschild & Co Redburn | Sell |
| Sep-10-25 | Reiterated | BMO Capital Markets | Outperform |
| Sep-10-25 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-10-25 | Upgrade | Citigroup | Neutral → Buy |
| Sep-09-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-17-25 | Initiated | Scotiabank | Sector Outperform |
| Jul-10-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-02-25 | Reiterated | BMO Capital Markets | Outperform |
| Jun-30-25 | Upgrade | Stifel | Hold → Buy |
| Jun-18-25 | Reiterated | Guggenheim | Buy |
| Jun-13-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Jun-09-25 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-23-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Mar-19-25 | Initiated | Stephens | Equal-Weight |
| Mar-11-25 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-03-25 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-24 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| Oct-23-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-16-24 | Upgrade | Melius | Hold → Buy |
| Sep-10-24 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-10-24 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jun-17-24 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-18-24 | Initiated | Oppenheimer | Perform |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-14-24 | Upgrade | Argus | Hold → Buy |
| Mar-12-24 | Reiterated | BMO Capital Markets | Market Perform |
| Mar-12-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-12-23 | Reiterated | BMO Capital Markets | Market Perform |
| Nov-13-23 | Upgrade | Edward Jones | Hold → Buy |
| Oct-09-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-15-23 | Initiated | HSBC Securities | Buy |
| Sep-14-23 | Upgrade | DZ Bank | Hold → Buy |
| Sep-13-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-12-23 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Sep-05-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-29-23 | Upgrade | UBS | Neutral → Buy |
| Jun-13-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Mar-10-23 | Downgrade | Societe Generale | Buy → Hold |
| Jan-18-23 | Initiated | DA Davidson | Neutral |
| Jan-11-23 | Initiated | Mizuho | Buy |
| Jan-09-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-05-23 | Upgrade | Jefferies | Hold → Buy |
| Oct-21-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Oct-20-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Sep-14-22 | Initiated | Berenberg | Hold |
| Aug-12-22 | Initiated | Guggenheim | Buy |
| Jun-29-22 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Jun-27-22 | Resumed | Goldman | Sell |
| Jun-14-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Apr-01-22 | Initiated | Daiwa Securities | Neutral |
| Mar-29-22 | Downgrade | Exane BNP Paribas | Neutral → Underperform |
| Mar-11-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-11-22 | Upgrade | Societe Generale | Hold → Buy |
| Dec-21-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Dec-15-21 | Upgrade | DZ Bank | Sell → Hold |
| Dec-10-21 | Reiterated | BMO Capital Markets | Market Perform |
| Dec-10-21 | Reiterated | Barclays | Equal Weight |
| Dec-10-21 | Reiterated | Citigroup | Neutral |
| Dec-10-21 | Reiterated | Cowen | Outperform |
| Dec-10-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Dec-10-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Dec-10-21 | Reiterated | Piper Sandler | Neutral |
| Dec-10-21 | Reiterated | Societe Generale | Hold |
| Dec-10-21 | Reiterated | Stifel | Hold |
| Dec-10-21 | Reiterated | UBS | Neutral |
| Dec-10-21 | Reiterated | Wolfe Research | Peer Perform |
| Nov-16-21 | Initiated | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Hold |
| Sep-14-21 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-14-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Aug-10-21 | Downgrade | DZ Bank | Hold → Sell |
| May-10-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-23-21 | Initiated | Wolfe Research | Peer Perform |
| Apr-21-21 | Downgrade | DZ Bank | Buy → Hold |
| Apr-01-21 | Resumed | Wedbush | Neutral |
| Mar-22-21 | Resumed | Evercore ISI | In-line |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-11-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Mar-11-21 | Downgrade | Societe Generale | Buy → Hold |
| Mar-05-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-21 | Resumed | Citigroup | Neutral |
| Jan-22-21 | Initiated | Goldman | Sell |
| Dec-18-20 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Neutral |
| Dec-08-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Resumed | UBS | Neutral |
| Sep-21-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Sep-11-20 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-11-20 | Reiterated | Barclays | Equal Weight |
| Sep-11-20 | Reiterated | Credit Suisse | Outperform |
| Sep-11-20 | Reiterated | Goldman | Buy |
| Sep-11-20 | Reiterated | Jefferies | Hold |
| Sep-11-20 | Reiterated | Morgan Stanley | Equal-Weight |
| Sep-11-20 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-11-20 | Reiterated | Stifel | Hold |
| Sep-11-20 | Reiterated | Wells Fargo | Overweight |
| Jun-19-20 | Downgrade | Argus | Buy → Hold |
| Jun-01-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Mar-31-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-20-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-13-20 | Reiterated | BMO Capital Markets | Market Perform |
View All
Oracle Corp Stock (ORCL) Latest News
ORACLE CORPORATION (ORCL) INVESTOR ALERT Investors With - GlobeNewswire
Eli Lilly and Oracle among market cap stock movers on Thursday - Investing.com UK
Investors sue Oracle, allege executives dumped $1.87B amid AI hype - InvestmentNews
Curtain call: Longtime East Bank tenants clear out for Oracle - The Business Journals
Bronstein, Gewirtz & Grossman LLC Urges Oracle Corporation - GlobeNewswire
3 Reasons to Hold Oracle Stock Despite 43% Decline in 6 Months - Zacks Investment Research
Oracle Could Cut 30,000 Jobs, Sell Cerner Amid Financial Challenges - Samfiru Tumarkin LLP
Oracle Stock (ORCL) Opinions on $45-50 Billion AI Capital Raise - Quiver Quantitative
Oracle Database@AWS adds new regions in Canada and Australia - Data Center Dynamics
Oracle's Larry Ellison is down an unmatched $49 billion this year after the plunge in software stocks - Yahoo! Finance Canada
INVESTOR ALERT: Oracle Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - PR Newswire
INVESTIGATION NOTICE: Oracle Bondholders (ORCL) Who - GlobeNewswire
Oracle plans massive layoffs as AI expansion triggers financial strain - NewsFirst Prime
Ashton Thomas Private Wealth LLC Purchases 4,965 Shares of Oracle Corporation $ORCL - MarketBeat
Cullen Capital Management LLC Decreases Stock Position in Oracle Corporation $ORCL - MarketBeat
Oracle Corporation $ORCL Shares Purchased by SBI Securities Co. Ltd. - MarketBeat
Triglav Investments D.O.O. Reduces Stock Holdings in Oracle Corporation $ORCL - MarketBeat
First Fiduciary Investment Counsel Inc. Has $14.68 Million Stock Holdings in Oracle Corporation $ORCL - MarketBeat
Oracle Found Its Place In AI, Now Comes The Hard Part - Seeking Alpha
SouthState Bank Corp Has $49.56 Million Position in Oracle Corporation $ORCL - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Raises Position in Oracle Corporation $ORCL - MarketBeat
Driving innovation in AI transformation and multicloud - Oracle
Titleist Asset Management LLC Has $4.54 Million Stock Holdings in Oracle Corporation $ORCL - MarketBeat
Oracle makes a public clarification on the deal that analysts say will be behind company laying off up to - Times of India
Scotiabank Cuts Oracle (ORCL) Target to $220, Keeps Sector Outperform - Finviz
Scotiabank cuts Oracle (ORCL) target to $220, keeps sector outperform - MSN
Composable Applications Market to Hit USD 56.11 Billion by 2035, Fueled by Demand for Agile and Modular Digital Solutions | Research by SNS Insider - GlobeNewswire Inc.
Oracle Oversold AI Infrastructure Spending, Investor Says - Law360
Oracle to train 15,000 students and professionals in West Bengal - CRN Asia
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Oracle Corporation Securities Class Action Lawsuit - Business Wire
ORCL INVESTOR ALERT: Oracle Corporation Investors with - GlobeNewswire
Bank of Valletta taps Oracle for agentic AI solutions - FinAi News
Oracle Bolsters Financing with Major Senior Notes Issuance - TipRanks
Oracle (ORCL) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore
Oracle Signs At-The-Market Equity Distribution Agreement With Multiple Sales Agents - TradingView
Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces that the Firm has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm - Business Wire
Oracle Investor Sues Over Mounting Spending on AI Data Centers - Bloomberg Law News
Why Oracle Stock Fell Hard To Start 2026 - The Globe and Mail
Oracle analyst warns of 30,000 layoffs, asset sale as the cloud firm moves to tackle debt – ORCL stock falls pre-market - MSN
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Lawsuit - PR Newswire
Palmetto Grain Brokerage - Palmetto Grain Brokerage
30,000 Layoffs Could Soon Hit at Oracle. What Does That Mean for ORCL Stock? - Barchart.com
ROSEN, A LEADING LAW FIRM, Encourages Oracle Corporation Investors to Secure Counsel in ... - Bluefield Daily Telegraph
Oracle In Transition: Investor Prize Or Awkward Proposition? (NYSE:ORCL) - Seeking Alpha
Oracle financing plan removes key overhang, BMO says - Yahoo Finance
Oracle Teams Up With Canadian Healthcare Organizations To Launch Clinical AI Pilot ProjectOracle (NYSE:ORCL) - Benzinga
Oracle’s Record AI Capital Raise Reshapes Cloud Focus And Portfolio - simplywall.st
Lumeo health system selects Oracle AI tool for clinical documentation - StreetInsider
Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent to Help Physicians Spend More Time on Patient Care - Finviz
Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent to Help Physicians Spend More Time on Patient Care – Company AnnouncementFT.com - Financial Times
UBS cuts Oracle (ORCL) target but sees funding clarity as a catalyst - MSN
Oracle Corp Stock (ORCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):